State of Wyoming Has $657,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

State of Wyoming raised its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 22.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 50,114 shares of the company’s stock after buying an additional 9,296 shares during the quarter. State of Wyoming owned 0.06% of Pediatrix Medical Group worth $657,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in MD. Pacer Advisors Inc. acquired a new position in Pediatrix Medical Group in the fourth quarter valued at about $35,492,000. American Century Companies Inc. raised its position in shares of Pediatrix Medical Group by 628.2% during the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock worth $22,820,000 after purchasing an additional 1,500,485 shares during the period. Oberweis Asset Management Inc. acquired a new stake in shares of Pediatrix Medical Group during the fourth quarter worth about $6,122,000. Renaissance Technologies LLC raised its position in shares of Pediatrix Medical Group by 117.4% during the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock worth $11,005,000 after purchasing an additional 453,000 shares during the period. Finally, Boston Partners grew its holdings in shares of Pediatrix Medical Group by 25.2% during the fourth quarter. Boston Partners now owns 1,956,353 shares of the company’s stock worth $25,922,000 after buying an additional 393,600 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 0.1%

MD opened at $14.89 on Monday. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The company has a 50-day simple moving average of $13.71 and a 200 day simple moving average of $14.12. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $1.28 billion, a price-to-earnings ratio of -12.41, a P/E/G ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $458.36 million during the quarter, compared to analysts’ expectations of $451.44 million. During the same quarter in the prior year, the business posted $0.20 earnings per share. Pediatrix Medical Group’s revenue was down 7.4% compared to the same quarter last year. Analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MD has been the subject of a number of research reports. UBS Group decreased their price objective on Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a report on Monday, May 12th. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Thursday, May 8th. Finally, Truist Financial reduced their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average target price of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.